Events

Topic Summary

In 2021, one in every 100 kids aged 12-17 had an Opioid Use Disorder (OUD). Medication treatment for OUD (MOUD) is effective, but only 3-4% of youth who need it receive treatment. This session will outline features of youth treatment for OUD, evidence for treating youth with medications, youth MOUD uptake and retention, the role of families in care, and opportunities for interdisciplinary care teams in outpatient settings. In this extended session, Dr. Fishman will also facilitate interactive case reviews with attendees. If you have a case that you would like to present, please let us know.

Speaker Bio

Dr. Fishman is an addiction psychiatrist with extensive experience in clinical care of addiction patients, addiction research, and program development and administration in the real world. He leads Maryland Treatment Centers / Mountain Manor, a regional behavioral healthcare provider, which offers programs for residential and outpatient SUD and co-occurring treatment for youth and adults. He is a member of the psychiatry faculty at Johns Hopkins University School of Medicine. He has been an investigator on numerous research studies in addiction and published extensively in the field. His academic and research work has focused on addiction pharmacotherapy, particularly in OUD; models of care for youth; and treatment placement and matching strategies. He was a member of the Guideline Committee that developed the American Society of Addiction Medicine (ASAM) National Practice Guideline for the Treatment of OUD in 2015 and its update in 2020. He served as a co-editor for past editions of the ASAM Criteria for the Treatment of Substance-Related Disorders. He served as a past President of the Maryland Society of Addiction Medicine.